Zurzuvae was generally well-tolerated, with the most common side effects being sedation, somnolence and dizziness.

April 22 (Reuters) - Shares of Pharmaceutical Product Development Inc (PPD) fell as much as 18 percent to a four-year low Wednesday, a day after the clinical-research service provider lowered its full ...

Jan 14 (Reuters) - Pharmaceutical Product Development Inc , a large contract research company, forecast 2009 earnings above market estimates, and said it expects three milestone payments from its ...